141 related articles for article (PubMed ID: 20026081)
1. AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress.
Choi SH; Kim YW; Kim SG
Biochem Pharmacol; 2010 May; 79(9):1352-62. PubMed ID: 20026081
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway.
Shin SM; Cho IJ; Kim SG
Mol Pharmacol; 2009 Oct; 76(4):884-95. PubMed ID: 19620254
[TBL] [Abstract][Full Text] [Related]
3. Mitigation of carbon tetrachloride-induced hepatic injury by methylene blue, a repurposed drug, is mediated by dual inhibition of GSK3β downstream of PKA.
Wu HM; Lee CG; Hwang SJ; Kim SG
Br J Pharmacol; 2014 Jun; 171(11):2790-802. PubMed ID: 24641162
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
Shin SM; Kim SG
Mol Pharmacol; 2009 Jan; 75(1):242-53. PubMed ID: 18945820
[TBL] [Abstract][Full Text] [Related]
5. Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection.
Kwon YN; Shin SM; Cho IJ; Kim SG
Drug Metab Dispos; 2009 Jun; 37(6):1187-97. PubMed ID: 19299524
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.
Kim YM; Kim TH; Kim YW; Yang YM; Ryu DH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Dec; 49(11):1722-34. PubMed ID: 20840863
[TBL] [Abstract][Full Text] [Related]
7. Tryptanthrin prevents oxidative stress-mediated apoptosis through AMP-activated protein kinase-dependent p38 mitogen-activated protein kinase activation.
Jung EH; Jung JY; Ko HL; Kim JK; Park SM; Jung DH; Park CA; Kim YW; Ku SK; Cho IJ; Kim SC
Arch Pharm Res; 2017 Sep; 40(9):1071-1086. PubMed ID: 28828587
[TBL] [Abstract][Full Text] [Related]
8. Fyn inhibition by cycloalkane-fused 1,2-dithiole-3-thiones enhances antioxidant capacity and protects mitochondria from oxidative injury.
Koo JH; Lee WH; Lee CG; Kim SG
Mol Pharmacol; 2012 Jul; 82(1):27-36. PubMed ID: 22474169
[TBL] [Abstract][Full Text] [Related]
9. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
10. Liqustri lucidi Fructus inhibits hepatic injury and functions as an antioxidant by activation of AMP-activated protein kinase in vivo and in vitro.
Seo HL; Baek SY; Lee EH; Lee JH; Lee SG; Kim KY; Jang MH; Park MH; Kim JH; Kim KJ; Lee HS; Ahn SC; Lee JR; Park SJ; Kim SC; Kim YW
Chem Biol Interact; 2017 Jan; 262():57-68. PubMed ID: 27916511
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells.
Son HS; Kwon HY; Sohn EJ; Lee JH; Woo HJ; Yun M; Kim SH; Kim YC
Phytother Res; 2013 Nov; 27(11):1714-22. PubMed ID: 23325562
[TBL] [Abstract][Full Text] [Related]
12. AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction.
Dong GZ; Lee JH; Ki SH; Yang JH; Cho IJ; Kang SH; Zhao RJ; Kim SC; Kim YW
Eur J Pharmacol; 2014 Oct; 740():634-40. PubMed ID: 24972246
[TBL] [Abstract][Full Text] [Related]
13. AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor.
Jung EH; Lee JH; Kim SC; Kim YW
Eur J Nutr; 2017 Mar; 56(2):635-647. PubMed ID: 26646674
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy.
Yerra VG; Kalvala AK; Kumar A
J Nutr Biochem; 2017 Sep; 47():41-52. PubMed ID: 28528294
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin ameliorates oxidative hepatic damage through AMP-activated protein kinase, facilitating autophagy.
Kim KY; Lee SG; Baek SY; Lee EH; Jang EJ; Lee JH; Ahn SC; Chang JH; Oh TW; Kim SH; Ma JY; Kim SC; Park KI; Kim YW
Toxicol Appl Pharmacol; 2018 Dec; 360():141-149. PubMed ID: 30290169
[TBL] [Abstract][Full Text] [Related]
16. Redox-sensitive glycogen synthase kinase 3β-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury.
Wang Z; Ge Y; Bao H; Dworkin L; Peng A; Gong R
Free Radic Biol Med; 2013 Dec; 65():849-858. PubMed ID: 23973862
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury.
Kim YW; Lee SM; Shin SM; Hwang SJ; Brooks JS; Kang HE; Lee MG; Kim SC; Kim SG
Free Radic Biol Med; 2009 Oct; 47(7):1082-92. PubMed ID: 19616619
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
19. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity.
Seo K; Ki SH; Shin SM
Cell Signal; 2015 Jul; 27(7):1533-43. PubMed ID: 25778901
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin inhibits mouse S180 tumors with a new mechanism that regulates autophagy by GSK-3β/TNF-α pathway.
Yushan R; Ying Y; Yujun T; Jingchun Y; Dongguang L; Lihong P; Pingping W; Lili Z; Fanhui Z; Zhong L; Guimin Z; Jie L
Eur J Pharmacol; 2018 Nov; 838():11-22. PubMed ID: 30171855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
